ADAR1 Capital Management, LLC's Trading History
| INMInMed Pharmaceuticals | Oct 27, 2026 | Ten Percent Owner | Informative Buy | 5.28 | $1.56M | |
| NXTCNextCure | Oct 27, 2026 | Ten Percent Owner | Informative Buy | 53.61K | $4.18M | |
| TENXTenax Therapeutics | Oct 21, 2026 | Ten Percent Owner | Informative Buy | 1.46M | $13.40M | |
| RLYBRallybio | May 20, 2026 | Ten Percent Owner | Informative Buy | 226.51K | $14.60M | |
| KROSKeros Therapeutics | Oct 15, 2025 | Ten Percent Owner | Informative Sell | 95.66M | $0.00 | |
| PVLAPalvella Therapeutics | Aug 12, 2024 | Ten Percent Owner | Informative Buy | 92.31K | $21.17M |
You May Also Like
ADAR1 Capital Management, LLC insider profile FAQ
What is the percentage of profitable transactions made by ADAR1 Capital Management, LLC?
The percentage of profitable transactions made by ADAR1 Capital Management, LLC is 82%.
What is the average return per transaction made by ADAR1 Capital Management, LLC?
The average return per transaction made by ADAR1 Capital Management, LLC is 18.80%.
What stocks does ADAR1 Capital Management, LLC hold?
ADAR1 Capital Management, LLC holds: NXTC, TENX, PVLA, INM, KROS, RLYB stocks.
What was ADAR1 Capital Management, LLC’s latest transaction?
ADAR1 Capital Management, LLC’s latest transaction was an Informative Buy of $53.61K.
What was ADAR1 Capital Management, LLC's most profitable transaction?
ADAR1 Capital Management, LLC’s most profitable transaction was an Informative Buy of PVLA stock on August 12, 2024. The return on the trade was 171.90%.
What is ADAR1 Capital Management, LLC's role in NextCure?
ADAR1 Capital Management, LLC's role in NextCure is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.